Google News – FDA (biotech/pharma) External News
Regulatory & Compliance Articles
Google News – FDA (biotech/pharma) External News
Oncolytics Biotech® Reports FDA Regulatory Milestone and - GlobeNewswire
Google News – FDA (biotech/pharma) External News
FDA takes first step toward ‘de facto’ ad ban: What to know - PRWeek
Google News – FDA (biotech/pharma) External News
FDA proposal to modernize drug manufacturing registration - The Pharma Letter
Google News – FDA (biotech/pharma) External News
Tris Pharma’s CRL for narcolepsy drug; Agenus abandons Phase 3 CRC trial - Endpoints News
Google News – FDA (biotech/pharma) External News
Elevar liver cancer combo receives third FDA rejection - The Pharma Letter
Google News – Digital Health External News
Digital Health Startup Survival Guide: FDA, HIPAA, AI & Beyond - Goodwin Procter
Google News – Clinical Trials External News
Universal Brain Receives FDA 510(k) Clearance for Rapid Brain-Function Measurement Platform for Psychiatry - AOL.com
Google News – Clinical Trials External News
As Ebola Spreads in Two More Provinces, NanoViricides Has Received National Ethics Committee Approval for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola in Congo - ACCESS Newswire
Google News – Clinical Trials External News
Psychedelics: FDA offers clarifications, compromises in final clinical trial guidance - RAPS
Google News – Clinical Trials External News
FDA Approves LEQEMBI IQLIK® (lecanemab-irmb) Subcutaneous Injection as an Initiation Dose for Early Alzheimer’s Disease - Biogen
Google News – Clinical Trials External News
“Hub-and-spoke” drug manufacturing set to benefit from new FDA rule - Clinical Trials Arena
Google News – Clinical Trials External News
FDA approves clinical testing of CAR T-cell therapy for AAV, other conditions - ANCA Vasculitis News
Google News – Clinical Trials External News
FDA Issues CRL to Elevar Therpaeutics for Combination of Rivoceranib and Camrelizumab - Pharmaceutical Executive
Google News – Clinical Trials External News